Edition:
United States

Profile: Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

33.12USD
15 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$33.12
Open
--
Day's High
--
Day's Low
--
Volume
700
Avg. Vol
821,989
52-wk High
$52.52
52-wk Low
$2.14

Tandem Diabetes Care, Inc., incorporated on January 7, 2008, is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells over three insulin pump products in the United States that are designed to address insulin-dependent diabetes market, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). The Company's technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. The Company also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

The Company's t:slim Insulin Delivery System consists of t:slim Pump, and it has 300-unit disposable insulin cartridge and an infusion set. Its t:flex Insulin Delivery System consists of t:flex Pump, and it has 480-unit disposable insulin cartridge and an infusion set. Its t:slim G4 Insulin Delivery System is the touch-screen pump with continuous glucose monitoring (CGM) integration. It offers its customers with various infusion set choices for use with its insulin pump products. The Company offers its customers a range of accessories for the pumps, allowing users to customize the device. The accessories include various color casings, belt clips and leather cases.

The Company is developing Tandem Device Updater, formerly referred to as Project Odyssey, is a personal computer (PC) and Mac-compatible Web-based system that is being developed to give users the ability to update their pump's software remotely. The Company also focuses to develop t:sport Insulin Delivery System, or t:sport, is being designed for people who seek even greater discretion and flexibility with the use of their insulin pump by further reducing the size of the insulin pump and controlling its operation through a separate controller or mobile device application.

The Company competes with Medtronic, Inc., Johnson & Johnson and Insulet Corporation.

Company Address

Tandem Diabetes Care Inc

11075 Roselle St
SAN DIEGO   CA   92121-1204
P: +1858.3666900
F: +1302.6365454

Company Web Links